Rothblatt Martine A
ROTHBLATT MARTINE A, CHAIR, CEO, reported a transaction classified as exercise at UNITED THERAPEUTICS Corp involving 9500.000000 shares for an estimated $0.00. Reported holdings after the transaction were 261910.000000 shares. The stored filing text includes a detected 10b5-1 reference.
- Trade date
- Oct 09, 2026
- Filing date
- Oct 13, 2026
How reported position traded is calculated
Not calculated for derivative securities.
Row-level estimate for this security and ownership context, not the insider’s complete portfolio. Joint ownership, other transactions in the filing, amendments and footnotes can affect interpretation.
UTHR price since this filing
Daily closing prices, with the filing date and available return windowsTransaction facts
Stored Form 4 columns with their raw values
- Type
- exercise Code M
- Identifier
- 0001106578-26-000161 Stock Option
- Transaction date
- Oct 09, 2026 Filed Oct 13, 2026, 08:30 PM · 4d delay
- Shares
- 9,500 sh $0.00 per share
- Estimated value
- $0 Computed from shares × price
- Holdings after
- 261,910 sh Indirect · by Trust
Filing signal explanations
Badges describe filing facts only — not predictions.
-26 points
Compact filing score computed from stored Form 4 facts. Version v1.
This filing has a meaningfully negative filing-only score. It is likely less useful as a positive insider-activity signal.
How this score is calculated
- derivative_transaction-16 points
is_derivative = true
Derivative exercise rows are less discretionary than open-market purchases. - tenb5_1_detected-10 points
is_10b5_1 = true
Stored filing content includes detected 10b5-1 language.
Signed filing-only points, not a probability or expected return. Version v1.
Reported relationships & other filings
Form 4 relationship flags and nearby filing context
Chairperson & CEO
- F1
This exercise of stock options and sale of the resulting shares of common stock was pursuant to a pre-arranged 10b5-1 trading plan adopted by the reporting person on November 7, 2025. This plan will c…
- F10
This transaction was executed in multiple trades at prices ranging from $542.57 to $543.47. The price reported above reflects the weighted average price. The reporting person hereby undertakes to prov…
- F11
This transaction was executed in multiple trades at prices ranging from $544.20 to $545.07. The price reported above reflects the weighted average price. The reporting person hereby undertakes to prov…
- F12
This transaction was executed in multiple trades at prices ranging from $545.20 to $546.18. The price reported above reflects the weighted average price. The reporting person hereby undertakes to prov…
- F13
This transaction was executed in multiple trades at prices ranging from $546.36 to $546.86. The price reported above reflects the weighted average price. The reporting person hereby undertakes to prov…
- F14
This transaction was executed in multiple trades at prices ranging from $547.37 to $548.33. The price reported above reflects the weighted average price. The reporting person hereby undertakes to prov…
- F15
This transaction was executed in multiple trades at prices ranging from $548.44 to $549.43. The price reported above reflects the weighted average price. The reporting person hereby undertakes to prov…
- F16
This transaction was executed in multiple trades at prices ranging from $549.46 to $550.37. The price reported above reflects the weighted average price. The reporting person hereby undertakes to prov…
- F17
This transaction was executed in multiple trades at prices ranging from $550.46 to $551.04. The price reported above reflects the weighted average price. The reporting person hereby undertakes to prov…
- F18
Shares held in family trusts as to which the Reporting Person's spouse is sole trustee and sole beneficiary or co-trustee and settlor with power to revoke.
- F19
Shares held in family trusts as to which the Reporting Person's spouse shares investment power and the Reporting Person and/or immediate family members are beneficiaries.
- F2
Shares held in family trusts as to which the Reporting Person shares investment power and the Reporting Person and/or immediate family members are beneficiaries.
- F20
Shares held in family trusts as to which the Reporting Person is sole trustee and sole beneficiary or co-trustee and settlor with power to revoke.
- F21
These stock options vested in equal one-third installments on March 15, 2021, 2022 and 2023.
- F22
Stock options held in a family trust as to which the Reporting Person shares investment power and the Reporting Person and immediate family members are beneficiaries.
- F3
This transaction was executed in multiple trades at prices ranging from $533.19 to $534.15. The price reported above reflects the weighted average price. The reporting person hereby undertakes to prov…
- F4
This transaction was executed in multiple trades at prices ranging from $534.40 to $535.34. The price reported above reflects the weighted average price. The reporting person hereby undertakes to prov…
- F5
This transaction was executed in multiple trades at prices ranging from $535.64 to $536.58. The price reported above reflects the weighted average price. The reporting person hereby undertakes to prov…
- F6
This transaction was executed in multiple trades at prices ranging from $536.72 to $537.57. The price reported above reflects the weighted average price. The reporting person hereby undertakes to prov…
- F7
This transaction was executed in multiple trades at prices ranging from $537.83 to $538.72. The price reported above reflects the weighted average price. The reporting person hereby undertakes to prov…
- F8
This transaction was executed in multiple trades at prices ranging from $538.87 to $539.58. The price reported above reflects the weighted average price. The reporting person hereby undertakes to prov…
- F9
This transaction was executed in multiple trades at prices ranging from $540.47 to $541.35. The price reported above reflects the weighted average price. The reporting person hereby undertakes to prov…
0 other transactions
0 recent txs